| Christoph H Eggert, MD | |
|
2840 Index Rd, Fitchburg, WI 53713-3117 | |
| (608) 229-7221 | |
| Not Available |
| Full Name | Christoph H Eggert |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 2840 Index Rd, Fitchburg, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598738247 | NPI | - | NPPES |
| 862952800 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 43642 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fresenius Medical Care - Madison Capitol | Madison, WI | Dialysis facility |
| Fresenius Medical Care - Dodgeville | Dodgeville, WI | Dialysis facility |
| Fresenius Medical Care - Baraboo | Baraboo, WI | Dialysis facility |
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Ssm Health St Clare Hospital - Baraboo | Baraboo, WI | Hospital |
| Meriter Hospital | Madison, WI | Hospital |
| Ssm Health St Mary's Hospital - Janesville | Janesville, WI | Hospital |
| Sauk Prairie Hospital | Prairie du sac, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Madison Area Renal Specialists Sc | 8628979432 | 6 |
News Archive
Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases have different sensitivities to radiation therapy based on the location of the primary tumor.
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
A Wayne State University research team led by Fei Sun, Ph.D., assistant professor of physiology in the School of Medicine, recently received a grant with an anticipated amount of nearly $1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to better understand how this defective protein in cystic fibrosis patients is prematurely digested.
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
› Verified 6 days ago
| Entity Name | Madison Area Renal Specialists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104834894 PECOS PAC ID: 8628979432 Enrollment ID: O20040115000585 |
News Archive
Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases have different sensitivities to radiation therapy based on the location of the primary tumor.
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
A Wayne State University research team led by Fei Sun, Ph.D., assistant professor of physiology in the School of Medicine, recently received a grant with an anticipated amount of nearly $1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to better understand how this defective protein in cystic fibrosis patients is prematurely digested.
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christoph H Eggert, MD 3833 Cardinal Point Trl, Verona, WI 53593-8141 Ph: (608) 203-6223 | Christoph H Eggert, MD 2840 Index Rd, Fitchburg, WI 53713-3117 Ph: (608) 229-7221 |
News Archive
Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases have different sensitivities to radiation therapy based on the location of the primary tumor.
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
A Wayne State University research team led by Fei Sun, Ph.D., assistant professor of physiology in the School of Medicine, recently received a grant with an anticipated amount of nearly $1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to better understand how this defective protein in cystic fibrosis patients is prematurely digested.
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
› Verified 6 days ago
Dr. Sarah E Panzer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3034 Fish Hatchery Rd, Fitchburg, WI 53713 Phone: 608-270-5600 | |
Jacalyn A Nelson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2844 Index Rd, Fitchburg, WI 53713 Phone: 608-229-7979 Fax: 608-229-8110 | |
Rachael Ziska, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3051 Cahill Main, Fitchburg, WI 53711 Phone: 608-661-7200 | |
Laura Maursetter, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3034 Fish Hatchery Rd, Fitchburg, WI 53713 Phone: 608-270-5656 | |
Dr. Daniel Joel Mcculley, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5543 E Cheryl Pkwy, Fitchburg, WI 53711 Phone: 608-263-7740 Fax: 608-262-6048 | |
Dr. Don A Harden, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2844 Index Rd, Fitchburg, WI 53713 Phone: 608-229-7979 Fax: 608-229-8110 | |
Uzoamaka E Achufusi, MBBS Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3034 Fish Hatchery Rd, Fitchburg, WI 53713 Phone: 608-270-5656 |